What happens when one of the rarest cancers has almost no treatment options left? University of Michigan researchers are testing a new targeted drug that is showing encouraging results against aggressive salivary gland cancers, offering fresh hope for patients facing a disease where therapies have remained largely unchanged for years.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.